BACKGROUND: Vitamin B12 status is measured by four plasma/ serum biomarkers: total vitamin B12 (total B12), holotranscobalamin (holoTC), methylmalonic acid (MMA) and homocysteine (tHcy). Associations of B12 intake with holoTC and tHcy and associations between all four biomarkers have not been extensively studied. A better insight in these associations may contribute to an improved differentiation between vitamin B12 deficiency and a normal vitamin B12 status. OBJECTIVE: This study investigates associations between vitamin B12 intake and biomarkers and associations between biomarkers. DESIGN: In this cross-sectional observational study, levels of total B12, HoloTC, MMA and tHcy were determined in participants of the B-PROOF study: 2919 elderly people (≥65 years, with a mean age of 74.1 years, a mean BMI of 27.1 and 50% women) with elevated tHcy levels (≥12 µmol/L). B12 intake was assessed in a subsample. We assessed the association between intake and status with multivariate regression analysis. We explored the dose-response association between B12 intake and biomarkers and the association of total B12 and holoTC with tHcy and MMA with restricted cubic spline plots. RESULTS: A doubling of B12 intake was associated with 9% higher total B12, 15% higher HoloTC, 9% lower MMA and 2% lower tHcy. Saturation of biomarkers occurs with dietary intakes of >5 μg B12. Spline regression showed that levels of MMA and tHcy started to rise when vitamin B12 levels fall below 330 pmol/L and with HoloTC levels below 100 pmol/L, with a sharp increase with levels of B12 and HoloTC below 220 and 50 pmol/L respectively. CONCLUSIONS: In this study we observed a significant association between vitamin B12 intake and vitamin B12 biomarkers and between the biomarkers. The observed inflections for total B12 and holoTC with MMA and tHcy could indicate cut-off levels for further testing for B12 deficiency and determining subclinical B12 deficiency.
BACKGROUND: Vitamin B12 status is measured by four plasma/ serum biomarkers: total vitamin B12 (total B12), holotranscobalamin (holoTC), methylmalonic acid (MMA) and homocysteine (tHcy). Associations of B12 intake with holoTC and tHcy and associations between all four biomarkers have not been extensively studied. A better insight in these associations may contribute to an improved differentiation between vitamin B12 deficiency and a normal vitamin B12 status. OBJECTIVE: This study investigates associations between vitamin B12 intake and biomarkers and associations between biomarkers. DESIGN: In this cross-sectional observational study, levels of total B12, HoloTC, MMA and tHcy were determined in participants of the B-PROOF study: 2919 elderly people (≥65 years, with a mean age of 74.1 years, a mean BMI of 27.1 and 50% women) with elevated tHcy levels (≥12 µmol/L). B12 intake was assessed in a subsample. We assessed the association between intake and status with multivariate regression analysis. We explored the dose-response association between B12 intake and biomarkers and the association of total B12 and holoTC with tHcy and MMA with restricted cubic spline plots. RESULTS: A doubling of B12 intake was associated with 9% higher total B12, 15% higher HoloTC, 9% lower MMA and 2% lower tHcy. Saturation of biomarkers occurs with dietary intakes of >5 μg B12. Spline regression showed that levels of MMA and tHcy started to rise when vitamin B12 levels fall below 330 pmol/L and with HoloTC levels below 100 pmol/L, with a sharp increase with levels of B12 and HoloTC below 220 and 50 pmol/L respectively. CONCLUSIONS: In this study we observed a significant association between vitamin B12 intake and vitamin B12 biomarkers and between the biomarkers. The observed inflections for total B12 and holoTC with MMA and tHcy could indicate cut-off levels for further testing for B12 deficiency and determining subclinical B12 deficiency.
Authors: Helga Refsum; Eha Nurk; A David Smith; Per M Ueland; Clara G Gjesdal; Ingvar Bjelland; Aage Tverdal; Grethe S Tell; Ottar Nygård; Stein E Vollset Journal: J Nutr Date: 2006-06 Impact factor: 4.798
Authors: Robert Clarke; Helga Refsum; Jacqueline Birks; John Grimley Evans; Carole Johnston; Paul Sherliker; Per M Ueland; Joern Schneede; Joseph McPartlin; Ebba Nexo; John M Scott Journal: Am J Clin Nutr Date: 2003-05 Impact factor: 7.045
Authors: D Z van Asselt; L C de Groot; W A van Staveren; H J Blom; R A Wevers; I Biemond; W H Hoefnagels Journal: Am J Clin Nutr Date: 1998-08 Impact factor: 7.045
Authors: Mustafa Vakur Bor; Kristina M von Castel-Roberts; Gail Pa Kauwell; Sally P Stabler; Robert H Allen; David R Maneval; Lynn B Bailey; Ebba Nexo Journal: Am J Clin Nutr Date: 2010-01-13 Impact factor: 7.045
Authors: Carla Dullemeijer; Olga W Souverein; Esmée L Doets; Hilko van der Voet; Janneke P van Wijngaarden; Waldo J de Boer; Maria Plada; Rosalie A M Dhonukshe-Rutten; Paulette H In 't Veld; Adrienne E J M Cavelaars; Lisette C P G M de Groot; Pieter van 't Veer Journal: Am J Clin Nutr Date: 2012-12-26 Impact factor: 7.045
Authors: Robert Clarke; J Grimley Evans; J Schneede; E Nexo; C Bates; A Fletcher; A Prentice; C Johnston; P M Ueland; H Refsum; P Sherliker; J Birks; G Whitlock; E Breeze; J M Scott Journal: Age Ageing Date: 2004-01 Impact factor: 10.668
Authors: Elizabeth A Yetley; Christine M Pfeiffer; Karen W Phinney; Regan L Bailey; Sheena Blackmore; Jay L Bock; Lawrence C Brody; Ralph Carmel; L Randy Curtin; Ramón A Durazo-Arvizu; John H Eckfeldt; Ralph Green; Jesse F Gregory; Andrew N Hoofnagle; Donald W Jacobsen; Paul F Jacques; David A Lacher; Anne M Molloy; Joseph Massaro; James L Mills; Ebba Nexo; Jeanne I Rader; Jacob Selhub; Christopher Sempos; Barry Shane; Sally Stabler; Patrick Stover; Tsunenobu Tamura; Alison Tedstone; Susan J Thorpe; Paul M Coates; Clifford L Johnson; Mary Frances Picciano Journal: Am J Clin Nutr Date: 2011-05-18 Impact factor: 7.045
Authors: Lindsay H Allen; Joshua W Miller; Lisette de Groot; Irwin H Rosenberg; A David Smith; Helga Refsum; Daniel J Raiten Journal: J Nutr Date: 2018-12-01 Impact factor: 4.798